We appreciate Dr. Meiling Liao and Dr. Jie Zhang for their help, as well as all patients and their families and the staffs participating in this research. References 1. Coleman RE: Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Selleckchem CHIR99021 Cancer Res 2006, 12:6243s-6249s.PubMedCrossRef 2. Clezardin P, Teti A, et al.: Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis 2007, 24:599–608.PubMedCrossRef 3. Zhang Y, Ma B, Fan Q: Mechanisms of breast cancer bone metastasis. Cancer Let 2010, 292:1–7.CrossRef 4. Wang H, Pan
K, Zhang HK, et al.: Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res {Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleck Anti-infection Compound Library|Selleck Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Selleckchem Anti-infection Compound Library|Selleckchem Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|Anti-infection Compound Library|Antiinfection Compound Library|buy Anti-infection Compound Library|Anti-infection Compound Library ic50|Anti-infection Compound Library price|Anti-infection Compound Library cost|Anti-infection Compound Library solubility dmso|Anti-infection Compound Library purchase|Anti-infection Compound Library manufacturer|Anti-infection Compound Library research buy|Anti-infection Compound Library order|Anti-infection Compound Library mouse|Anti-infection Compound Library chemical structure|Anti-infection Compound Library mw|Anti-infection Compound Library molecular weight|Anti-infection Compound Library datasheet|Anti-infection Compound Library supplier|Anti-infection Compound Library in vitro|Anti-infection Compound Library cell line|Anti-infection Compound Library concentration|Anti-infection Compound Library nmr|Anti-infection Compound Library in vivo|Anti-infection Compound Library clinical trial|Anti-infection Compound Library cell assay|Anti-infection Compound Library screening|Anti-infection Compound Library high throughput|buy Antiinfection Compound Library|Antiinfection Compound Library ic50|Antiinfection Compound Library price|Antiinfection Compound Library cost|Antiinfection Compound Library solubility dmso|Antiinfection Compound Library purchase|Antiinfection Compound Library manufacturer|Antiinfection Compound Library research buy|Antiinfection Compound Library order|Antiinfection Compound Library chemical structure|Antiinfection Compound Library datasheet|Antiinfection Compound Library supplier|Antiinfection Compound Library in vitro|Antiinfection Compound Library cell line|Antiinfection Compound Library concentration|Antiinfection Compound Library clinical trial|Antiinfection Compound Library cell assay|Antiinfection Compound Library screening|Antiinfection Compound Library high throughput|Anti-infection Compound high throughput screening| Clin Oncol 2008, 134:535–541.PubMedCrossRef 5. Fong YC, Liu SC, Huang CY, et al.: Osteopontin increases lung cancer cells migration via activation of the vβ3 integrin/FAK/Akt and NF-κB-dependent pathway. Lung Cancer 2009, 64:263–270.PubMedCrossRef 6. El-Tanani MK: Role of osteopontin in cellular signaling and metastatic phenotype. Front Biosci 2008, 13:4276–84.PubMedCrossRef 7. Wai PY, Guo L, Gao C, et al.: Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proIiferation. Surgery 2006, 140:132–140.PubMedCrossRef 8. Kang
Y, Siegel PM, Shu W, et al.: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537–549.PubMedCrossRef 9. Uemura T, Liu YK, Feng Y, et al.: The role of sialoprotein in recognition of bone surface by osteoblasts via integrin. Mat Sci Eng 1997, 4:303.CrossRef LBH589 nmr 10. Bellancene A, MerVille MP, Castronovo V: Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res l994, 54:2823. 11. Fp R, Chappel J, Alvarez JI, et al.: Interactions between the bone metrix proteins osteopontin and bone Fossariinae sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption.
J Biol Chem 1993, 268:9901–9907. 12. Waltregny D, Bellahcene A, de Leval X, et al.: Increased Expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 2000, 15:834–843.PubMedCrossRef 13. Myoui A, Nishimura R, Williams PJ, et al.: c-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 2003, 63:5028–5033.PubMed 14. Alarmo EL, Kallioniemi A: Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer 2010, 17:R123-R139.PubMedCrossRef 15. Ketolainen JM, Alarmo EL, Tuominen VJ, et al.: Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Res Treat 2010, 124:377–386.PubMedCrossRef 16. Spanjol J, Djordjeric G, Markic D, et al.